Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
UXLINK: Community Unanimously Approves Buyback and Strategic Reserve Proposal, with Monthly Buybacks of No Less Than 1% of Tokens

UXLINK: Community Unanimously Approves Buyback and Strategic Reserve Proposal, with Monthly Buybacks of No Less Than 1% of Tokens

Odaily星球日报Odaily星球日报2025/12/27 08:21
Show original

According to Odaily, UXLINK announced on the X platform that the community has unanimously approved the buyback and strategic reserve proposal. According to the execution plan, UXLINK will launch this plan in December, using project profits each month to buy back no less than 1% of the total UXLINK supply, which will then be deposited into the strategic reserve.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver

Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

智通财经•2026/11/05 02:41
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading

CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

智通财经•2026/11/05 01:51
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response

According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.

智通财经•2026/11/05 01:36